Drug Shortage Report for APO-CELECOXIB
| Report ID | 141840 |
| Drug Identification Number | 02418932 |
| Brand name | APO-CELECOXIB |
| Common or Proper name | CELECOXIB |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-06-28 |
| Estimated end date | 2022-02-18 |
| Actual end date | 2022-01-28 |
| Shortage status | Resolved |
| Updated date | 2022-01-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2022-01-31 | English | Compare |
| v22 | 2022-01-31 | French | Compare |